天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Wuhan Jingkangen Biomedical Technology Co., Ltd

Firmenname:Wuhan Jingkangen Biomedical Technology Co., Ltd
Telefon:13720134139 +86 -0-15871494362
E-Mail:orders@jknbiochem.com
Nationalit?t:China
URL: www.jknbiochem.com
Produkte insgesamt:5821
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59

Produktkatalog

DeflazacortDeflazacort14484-47-0C25H31NO6
prednisolonPrednisolon50-24-8C21H28O5
11α-Hydroxyprogesterone11-α-Hydroxypregn-4-en-3,20-dion80-75-1C21H30O3
Fludrocortisone acetateFludrocortison-21-acetat514-36-3C23H31FO6
Hydrocortisone 17-valerate11β,17,21-Trihydroxypregn-4-en-3,20-dion-17-valerat57524-89-7C26H38O6
cortisol sodium phosphatePregn-4-en-3,20-dion, 11,17-Dihydroxy-21-(phosphonooxy)-, Dinatriumsalz, (11β)-6000-74-4C21H29O8P.2Na
Hydrocortisone-17-butyrate11β,17,21-Trihydroxypregn-4-en-3,20-dion-17-butyrat13609-67-1C25H36O6
Triamcinolone Acetonide EP Impurity E9-Fluor-11β,21-dihydroxy-16α,17-(isopropylidendioxy)pregn-4-en-3,20-dion1524-86-3C24H33FO6
triamcinolone acetonide9-α-Fluor-11-β,21-dihydroxy-16-α,17-α-isopropylidendioxypregna-1,4-dien-3,20-dion76-25-5C24H31FO6
TriamcinoloneTriamcinolon124-94-7C21H27FO6
Budesonide16α(R),17-[Butylidenbis(oxy)]-11β,21-dihydroxypregna-1,4-dien-3,20-dion51372-29-3C25H34O6
Gepotidacin1075236-89-3C24H28N6O3
Hydrocortisone Sodium SuccinateHydrocortison-21-(natriumsuccinat)125-04-2C25H33O8.Na
CortisoneCortison53-06-5C21H28O5
BEMPEDOIC ACID738606-46-7C19H36O5
Prednisolone HemisuccinatePrednisolon-21-(hydrogensuccinat)2920-86-7C25H32O8
DifluprednateDifluprednat23674-86-4C27H34F2O7
loteprednol etabonate82034-46-6C24H31ClO7
Prednisolone Valeroacetate11β,17,21-Trihydroxypregna-1,4-dien-3,20-dion-21-acetat-17-valerat72064-79-0C28H38O7
Prednisolone phosphate sodiumPrednisolon-21-(dinatriumphosphat)125-02-0C21H27Na2O8P
Prednisone Phosphate Disodium Salt/17-Hydroxy-21-(phosphonooxy)pregna-1,4-diene-3,11,20-trione disodium saltPregna-1,4-dien-3,11,20-trion, 17-Hydroxy-21-(phosphonooxy)-, Dinatriumsalz33903-70-7C21H25Na2O8P
Anecortave Acetate17-α,21-Dihydroxypregna-4,9(11)-dien-3,20-dion-21-acetat7753-60-8C23H30O5
Clascoterone19608-29-8C24H34O5
ZN-c32376146-48-2C29H34N8O2
Fmoc-N'-methyltrityl-L-lysine167393-62-6C41H40N2O4
1H-1,4-Benzodiazepine-2-methanamine, 7-chloro-2,3-dihydro-5-phenyl-138729-68-7C16H16ClN3
NA58468-07-4
MK-1775955365-80-7C27H32N8O2
IAG9332714434-21-4
8H-[1,4]Diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one, 3-[[2-chloro-5-(ethoxymethyl)-4-pyrimidinyl]oxy]-9,10,11,12-tetrahydro-10-methyl-, (10R)-1887069-10-4C22 H20 Cl N5 O3 S
Bermekimab1401965-15-8
Research Grade Nemolizumab1476039-58-3
Isatuximab1461640-62-9
Lilotomab1453362-55-4
Indusatumab1497400-26-6
Navivumab1443004-16-7
Pepinemab2097151-87-4
Obiltoxaximab1351337-07-9
Rovalpituzumab1613313-01-1
Istiratumab1509928-04-4
Research Grade Cergutuzumab1509916-03-3
Trevogrumab1429201-24-0
Inebilizumab1299440-37-1
Brolucizumab1531589-13-5
Tesidolumab1531594-08-7
Elgemtumab1512559-37-3
Andecaliximab1518996-49-0
Indusatumab Vedotin1514889-12-3
Sevirumab138660-96-5
4-[4-(4-amino-1,2,5-oxadiazol-3-yl)-2-oxido-1,2,5-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine296244-55-8C6H4N8O4
Meplazumab2413715-21-4
Rinucumab1569263-06-4
Depatuxizumab1471999-69-5
Suptavumab1629615-23-1
Birtamimab1608108-91-3
Erenumab1582205-90-0
Fremanezumab1655501-53-3
Burosumab1610833-03-8
Eptinezumab1644539-04-7
Elezanumab1791416-49-3
Afasevikumab1589503-30-9
Tisotumab1418628-81-5
Landogrozumab1391726-30-9
Tilavonemab2096513-89-0
Research Grade Ifabotuzumab1234137-51-9
Tezepelumab1572943-04-4
Olendalizumab1337966-73-0
Research Grade Gontivimab1257358-38-5
Satralizumab1535963-91-7
Xentuzumab1417158-65-6
Refanezumab1233953-61-1
Enoblituzumab1353485-38-7
Cabiralizumab1613144-80-1
Ascrinvacumab1463459-96-2
Monalizumab1228763-95-8
Plozalizumab1610761-46-0
Bleselumab1453067-91-8
Opicinumab1422268-07-2
Clivatuzumab Tetraxetan1462876-11-4
Mirvetuximab1453084-36-0
Navicixizumab1638338-43-8
Prezalumab1523164-68-2
Laprituximab1622327-38-1
Naratuximab1622327-39-2
Vadastuximab1436390-63-4
Rivabazumab1627519-84-9
Tamtuvetmab1608122-71-9
Blontuvetmab1608112-78-2
Crotedumab1452387-69-7
Vonlerolizumab1638935-72-4
Lanadelumab1426055-14-2
Timolumab1073538-99-4
Carotuximab1268714-50-6
Domagrozumab1629605-31-7
Galcanezumab1578199-75-3
Research Grade Setrusumab1847394-95-9
Research Grade Apamistamab2097132-02-8
Duvortuxizumab1831098-91-9
Rozanolixizumab1584645-37-3
Lupartumab1640971-88-5
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2019 ? ChemicalBook. All rights reserved